These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 5481239)

  • 41. Side effects of L-dopa treatment.
    Greenburg J
    Pa Med; 1971 Apr; 74(4):55-6. PubMed ID: 5147645
    [No Abstract]   [Full Text] [Related]  

  • 42. Psychosis and other psychiatric manifestations of levodopa therapy.
    Celesia GG; Barr AN
    Arch Neurol; 1970 Sep; 23(3):193-200. PubMed ID: 5456717
    [No Abstract]   [Full Text] [Related]  

  • 43. [Psychic manifestations during treatment of Parkinson's disease with L-dopa].
    Bonduelle M
    Rev Neurol (Paris); 1970 Feb; 122(2):140. PubMed ID: 5517897
    [No Abstract]   [Full Text] [Related]  

  • 44. [Advances in the treatment of parkinsonism].
    Dowzenko A
    Neurol Neurochir Pol; 1972; 6(2):275-80. PubMed ID: 4555308
    [No Abstract]   [Full Text] [Related]  

  • 45. Preliminary clinical experience with L-dopa in endogenous depressions.
    Náhunek K; Svestka J; Kamenická V; Rodová A
    Act Nerv Super (Praha); 1972; 14(2):101-2. PubMed ID: 4557141
    [No Abstract]   [Full Text] [Related]  

  • 46. [Side effects occurring in the course of treatment of parkinsonism with L-dopa].
    Kuran W
    Neurol Neurochir Pol; 1973; 7(4):587-94. PubMed ID: 4583001
    [No Abstract]   [Full Text] [Related]  

  • 47. Levodopa in treating Parkinsonism.
    O'Doherty DS
    Am Fam Physician; 1971 Nov; 4(5):95-9. PubMed ID: 5117507
    [No Abstract]   [Full Text] [Related]  

  • 48. Hypersexual behavior complicating levodopa (I-dopa) therapy.
    Shapiro SK
    Minn Med; 1973 Jan; 56(1):58-9. PubMed ID: 4682591
    [No Abstract]   [Full Text] [Related]  

  • 49. Reversal of the glabellar reflex in Parkinsonism by L-dopa.
    Klawans HL; Goodwin JA
    J Neurol Neurosurg Psychiatry; 1969 Oct; 32(5):423-7. PubMed ID: 5360050
    [No Abstract]   [Full Text] [Related]  

  • 50. The clinical use of levodopa in the treatment of Parkinson's disease.
    McDowell FH; Markham CH; Lee JE; Treciokas LJ; Ansel RD
    Contemp Neurol Ser; 1971; 8():175-201. PubMed ID: 4950056
    [No Abstract]   [Full Text] [Related]  

  • 51. L-Dopa therapy of Parkinson's disease. (A review of the preliminary experience at West Virginia University).
    Gutmann L; Martin JD; Gutrecht JA
    W V Med J; 1970 Apr; 66(4):109-11. PubMed ID: 5264660
    [No Abstract]   [Full Text] [Related]  

  • 52. L-dopa therapy in Parkinson's disease.
    Lipman IJ
    Va Med Mon (1918); 1971 May; 98(5):242-8. PubMed ID: 4931138
    [No Abstract]   [Full Text] [Related]  

  • 53. Amantadine hydrochloride in treatment of Parkinsonism.
    Nagaswami S; Nagaswami R
    Dis Nerv Syst; 1973; 34(5):253-8. PubMed ID: 4782280
    [No Abstract]   [Full Text] [Related]  

  • 54. Quantitative effects of L-dopa on different types of movements and muscle tone in Parkinsonian patients.
    Knutsson E; Mårtensson A
    Scand J Rehabil Med; 1971; 3(3):121-30. PubMed ID: 5156174
    [No Abstract]   [Full Text] [Related]  

  • 55. [Levodopa and Parkinsonism. A double-blind study].
    Pakkenberg H; Dupont E; Garde B; Hansen E; Melsen S; Vestberg F
    Ugeskr Laeger; 1971 Nov; 133(46):2275-9. PubMed ID: 4944650
    [No Abstract]   [Full Text] [Related]  

  • 56. L-Dopa treatment in Parkinson's Disease.
    Rinne UK; Sonninen V; Siirtola T
    Eur Neurol; 1970; 4(6):348-69. PubMed ID: 4932969
    [No Abstract]   [Full Text] [Related]  

  • 57. [Effect of a decarboxylase inhibitor (Ro 4-4602) in combination with L-dopa on inhibited depressions].
    Matussek N; Benkert O; Schneider K; Otten H; Pohlmeier H
    Arzneimittelforschung; 1970 Jul; 20(7):934-5. PubMed ID: 4918921
    [No Abstract]   [Full Text] [Related]  

  • 58. The patient's view of L-Dopa after one year's therapy.
    Hildick-Smith M
    Gerontol Clin (Basel); 1973; 15(2):74-83. PubMed ID: 4753782
    [No Abstract]   [Full Text] [Related]  

  • 59. Comparative trial of benzhexol, amantadine, and levodopa in the treatment of Parkinson's disease.
    Parkes JD; Baxter RC; Marsden CD; Rees JE
    J Neurol Neurosurg Psychiatry; 1974 Apr; 37(4):422-6. PubMed ID: 4838913
    [TBL] [Abstract][Full Text] [Related]  

  • 60. L-dopa for parkinsonism.
    Reveno WS; Bauer RB; Rosenbaum H
    Geriatrics; 1973 Jan; 28(1):86-8. PubMed ID: 4683093
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.